Shiu-chung Au

A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.

Eva Volf, Shiu-chung Au, Nicole Dumont et al. · PubMed · 2012 · 88 citations

Medicine, Dermatology, Pharmacology +17

A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies.

Adriane A. Levin, Alice B. Gottlieb, Shiu-chung Au · PubMed · 2014 · 75 citations

Medicine, Dermatology, Pharmacotherapy +8

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

Shiu-chung Au, Ari M. Goldminz, Noori Kim et al. · Journal of Dermatological Treatment · 2012 · 67 citations

Medicine, Dermatology, Pharmacotherapy +13

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

Ari M. Goldminz, Catherine D. Buzney, Noori Kim et al. · Pediatric Dermatology · 2013 · 65 citations

Medicine, Dermatology, Pediatrics +15

Continuous versus intermittent therapy for moderate-to-severe psoriasis.

Marigdalia K. Ramirez‐Fort, Adriane A. Levin, Shiu-chung Au et al. · PubMed · 2013 · 46 citations

Medicine, Dermatology, Pharmacotherapy +17